Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121913483
rs121913483
FGFR3
0.820 GeneticVariation UNIPROT Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. 10471491

1999
dbSNP: rs121913483
rs121913483
FGFR3
0.820 GeneticVariation UNIPROT Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma. 11314002

2001
dbSNP: rs121913482
rs121913482
FGFR3
0.800 GeneticVariation UNIPROT Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma. 11314002

2001
dbSNP: rs121913482
rs121913482
FGFR3
0.800 GeneticVariation UNIPROT Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. 10471491

1999
dbSNP: rs121913530
rs121913530
KRAS
0.800 GeneticVariation UNIPROT

dbSNP: rs78311289
rs78311289
FGFR3
0.800 GeneticVariation UNIPROT Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma. 11314002

2001
dbSNP: rs78311289
rs78311289
FGFR3
0.800 GeneticVariation UNIPROT Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. 10471491

1999
dbSNP: rs121913479
rs121913479
FGFR3
0.700 GeneticVariation UNIPROT Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. 10471491

1999
dbSNP: rs121913479
rs121913479
FGFR3
0.700 GeneticVariation UNIPROT Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma. 11314002

2001
dbSNP: rs28897728
rs28897728
BRCA2
0.700 GeneticVariation UNIPROT

dbSNP: rs2294008
rs2294008
PSCA ; JRK
T 0.800 GeneticVariation GWASDB Our data identify rs2294008 as a new bladder cancer susceptibility locus. 19648920

2009
dbSNP: rs2294008
rs2294008
PSCA ; JRK
T 0.800 GeneticVariation GWASDB A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. 20972438

2010
dbSNP: rs798766
rs798766
TACC3
T 0.770 GeneticVariation GWASDB A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. 20972438

2010
dbSNP: rs798766
rs798766
TACC3
T 0.770 GeneticVariation GWASDB Genome-wide association study identifies multiple loci associated with bladder cancer risk. 24163127

2014
dbSNP: rs798766
rs798766
TACC3
T 0.770 GeneticVariation GWASDB The T allele of rs798766 on 4p16.3 was found to associate with UBC (odds ratio = 1.24, P = 9.9 x 10(-12)). rs798766 is located in an intron of TACC3, 70 kb from FGFR3, which often harbors activating somatic mutations in low-grade, noninvasive UBC. 20348956

2010
dbSNP: rs9642880
rs9642880
CASC11
T 0.760 GeneticVariation GWASDB Genome-wide association study identifies multiple loci associated with bladder cancer risk. 24163127

2014
dbSNP: rs9642880
rs9642880
CASC11
T 0.760 GeneticVariation GWASDB No association was observed between UBC and the four 8q24 variants previously associated with prostate, colorectal and breast cancers, nor did rs9642880 associate with any of these three cancers. 18794855

2008
dbSNP: rs9642880
rs9642880
CASC11
T 0.760 GeneticVariation GWASDB A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. 20348956

2010
dbSNP: rs9642880
rs9642880
CASC11
T 0.760 GeneticVariation GWASDB A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. 20972438

2010
dbSNP: rs710521
rs710521 		A 0.740 GeneticVariation GWASDB A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. 20972438

2010
dbSNP: rs710521
rs710521 		A 0.740 GeneticVariation GWASDB Genome-wide association study identifies multiple loci associated with bladder cancer risk. 24163127

2014
dbSNP: rs710521
rs710521 		A 0.740 GeneticVariation GWASDB Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. 18794855

2008
dbSNP: rs710521
rs710521 		A 0.740 GeneticVariation GWASDB A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. 20348956

2010
dbSNP: rs11892031
rs11892031
UGT1A10 ; UGT1A8
0.730 GeneticVariation GWASDB In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 × 10⁻¹²) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 × 10⁻¹¹) on 19q12 maps to CCNE1 and rs11892031 (P = 1 × 10⁻⁷) maps to the UGT1A cluster on 2q37.1. 20972438

2010
dbSNP: rs11892031
rs11892031
UGT1A10 ; UGT1A8
A 0.730 GeneticVariation GWASDB Genome-wide association study identifies multiple loci associated with bladder cancer risk. 24163127

2014